2016
DOI: 10.1055/s-0042-109392
|View full text |Cite
|
Sign up to set email alerts
|

QSAR Studies and Design of Some Tetracyclic 1,4-Benzothiazines as Antimicrobial Agents

Abstract: A quantitative structure-activity relationship (QSAR) analysis has been performed on a series of 20 tetracyclic 1,4-benzothiazines (1a-1t) with antimicrobial activity to explain the observed biological activity trend on structural basis. Multiple linear regression (MLR) method was employed to establish statistically significant QSAR models. The developed models are robust, predictive and free from chance correlation with good fitting ability and sufficient generalizability. These studies revealed the dominance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 28 publications
(32 reference statements)
0
7
0
Order By: Relevance
“…QSAR modeling and validation: The QSAR models were developed using multiple linear regression procedure in QSARINS. The resulted QSAR models were evaluated using different parameters suggested in literature [29]. [26].…”
Section: Methodsmentioning
confidence: 99%
“…QSAR modeling and validation: The QSAR models were developed using multiple linear regression procedure in QSARINS. The resulted QSAR models were evaluated using different parameters suggested in literature [29]. [26].…”
Section: Methodsmentioning
confidence: 99%
“…53 Using these data, MLR was applied to establish antimicrobial activity QSAR models against these microorganisms. 54 After determining that WHIM parameters (Weighted Holistic Invariant Molecular descriptors) were dominant in determining the compound's activity, some of the molecules used in developing the model were modified in order to improve their activity. Another important contribution of QSAR models to antibacterial development is the improvement of existing drugs.…”
Section: Qsar In Antibacterial Compound Developmentmentioning
confidence: 99%
“…QSAR modeling is a process to select the therapeutically active drug molecules prior to their testing in more exhaustive procedures and experimental measurements. Using this method, the biological profile of the newly designed drug candidates can be envisaged before deciding about the final synthesis experiment [1,2]. However, QSAR mod-eling must be performed in accordance with the rules framed by Organisation for Economic Cooperation and Development (OECD) [3].…”
Section: Introductionmentioning
confidence: 99%
“…; R 2 = 0.8253; Q 2 = 0.7632; R 2 − Q 2 = 0.0621; s = 0.520; MAE = 0.416; F = 61 (sub − training set) n = 14; R 2 = 0.8273; Q 2 = 0.7746; R 2 − Q 2 = 0.0527; s = 0.550; MAE = 0.420 (calibration set) n = 08; R 2 = 0.7788; Q 2 = 0.5802; R 2 − Q2 = 0.1986; s = 0.996; MAE = 0.821 (test set) n = 06; R 2 = 0.8769; s = 0.469; MAE = 0.606 (validation set) ; R 2 = 0.8660; Q 2 = 0.8268; R 2 − Q 2 = 0.0392; s = 0.430; MAE = 0.362; F = 78 (sub − training set) n = 14; R 2 = 0.8696; Q 2 = 0.8106; R 2 − Q 2 = 0.0590; s = 0.467; MAE = 0.377 (calibration set) n = 08; R 2 = 0.8793; Q 2 = 0.7590; R 2 − Q 2 = 0.1203; s = 0.507; MAE = 0.416 (test set) n = 07; R 2 = 0.7556; s = 0.569; MAE = 0.686 (validation set) ; R 2 = 0.9502; Q 2 = 0.9388; R 2 − Q 2 = 0.0114; s = 0.275; MAE = 0.209; F = 248 (sub − training set) n = 14; R 2 = 0.9376; Q 2 = 0.9219; R 2 − Q 2 = 0.0157; s = 0.444; MAE = 0.367 (calibration set) n = 07; R 2 = 0.9469; Q 2 = 0.9083; R 2 − Q 2 = 0.0386; s = 0.560; MAE = 0.450 (test set) n = 07; R 2 = 0.9003; s = 0.374; MAE = 0.338 (validation set)…”
mentioning
confidence: 99%